dc.contributor.author | Ekici, Baris | |
dc.contributor.author | Akdogan, Basri | |
dc.contributor.author | Kir, Nur | |
dc.contributor.author | Aydinoglu-Candan, Ozlem | |
dc.contributor.author | Demirel, Atalay | |
dc.contributor.author | Ozmen, Meral | |
dc.contributor.author | ARAZ-ERSAN, Bilge | |
dc.contributor.author | Yildiz-Inec, Dilbade | |
dc.contributor.author | Tuncer, Samuray | |
dc.date.accessioned | 2021-03-03T18:41:21Z | |
dc.date.available | 2021-03-03T18:41:21Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | ARAZ-ERSAN B., Kir N., Tuncer S., Aydinoglu-Candan O., Yildiz-Inec D., Akdogan B., Ekici B., Demirel A., Ozmen M., "Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity", CURRENT EYE RESEARCH, cilt.40, sa.6, ss.585-591, 2015 | |
dc.identifier.issn | 0271-3683 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_507252e6-19c4-4b41-bc7c-9d5942626203 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/57272 | |
dc.identifier.uri | https://doi.org/10.3109/02713683.2014.941070 | |
dc.description.abstract | Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | OFTALMOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Göz Hastalıkları ve Cerrahisi | |
dc.title | Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity | |
dc.type | Makale | |
dc.relation.journal | CURRENT EYE RESEARCH | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 585 | |
dc.identifier.endpage | 591 | |
dc.contributor.firstauthorID | 70380 | |